1. Becker A, Buechele T, Sandner A. et al. Reirradiation of squamous cell carcinomas of the head and neck (SCCHN) combined with simultaneous paclitaxel (PAC) in a twice-a-week schedule (Results of a phase I/II-study). Proc Am Soc Clin Oncol 1998. abstract 1551.
2. Chougule P, Wanebo H, Akhtar M, et al. Concurrent paclitaxel, carboplatin and radiotherapy in advanced head and neck cancers: A phase II study. Proc Am Soc Clin Oncol 1998;17.abstract 1468.
3. Choy H, Browne MJ. Paclitaxel as radiation sensitizer in non-small-cell lung cancer. Semin Oncol 1995;22:Suppl 6:70–4.
4. Dunphy F, Boyd J, Varvares M, et al. Phase I trial of preoperative (PRE) chemotherapy using paclitaxel/paraplatin in head and neck carcinoma (HNCA). Proc Am Soc Clin Oncol 1996.abstract 892.
5. Elomaa L, Joensuu H, Kulmala J, et al. Squamous cell carcinoma is highly sensitive to Taxol®, a possible new radiation sensitizer. Acta Otolaryngol (Stockh) 1995;340-4.